pharma deals

The deal value was not disclosed

Once the deal is complete, Serum Institute Life Sciences will have about 15 per cent stake in Biocon Biologics, according to the…

Under the terms of the agreement, Cugene will receive an upfront payment of $48.5 million, and will also be eligible to receive…

This digital innovation represents impactful progress industry-wide, as it opens an opportunity for many life sciences…

The MoU will see both the entities work towards promoting research and innovation to increase impact of vaccines, technologies and…

Pfizer will acquire all the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, a 78.6 per…

The industry reported 113 Venture Capital (VC) deals worth $2.6 billion in April 2022, compared to the last 12-month average…

The deal will be financed by Rs 3,000 million of internal accruals and Rs 3,500 million of borrowings

The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and…

With this acquisition, Akums will boost its production capacities for general oral tablets and oral liquids